Roivant and Priovant Therapeutics hold an investor webinar on Brepocitinib and the Unmet Medical Need in Dermatomyositis on June 17 at 1 pm. roiv/register.aspx?conf=cc&page=roiv&url=https://wsw.com/webcast/cc/roiv/1393344′ target= ‘_blank’; rel=’nofollow’>Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROIV:
- Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
- Pulmovant announces publication of PK, lung deposition data for mosliciguat
- Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
- Roivant Sciences Reports Progress and Financial Results
- Roivant Sciences Earnings Call: Balancing Growth and Challenges